Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001694361 | SCV001907899 | likely benign | not provided | 2018-09-20 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001806246 | SCV002053536 | likely benign | Cardiomyopathy | 2021-05-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008961 | SCV004834773 | likely benign | Hypertrophic cardiomyopathy | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004651700 | SCV005144247 | likely benign | Cardiovascular phenotype | 2024-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV004008961 | SCV005824176 | likely benign | Hypertrophic cardiomyopathy | 2024-11-26 | criteria provided, single submitter | clinical testing |